FIGS (FIGS) Gains On Raised Outlooks, Is The Stock Fully Priced?
FIGS (FIGS) is back on investor radar after Wall Street highlighted its strong second quarter, with raised full-year earnings estimates setting the stage for an eagerly watched third-quarter update on November 5.
The recent rally in FIGS has been sharp. The share price is now $21.94, with a 30-day share price return of 60.97%, building on a 90-day move of 95.20% and a 1-year total shareholder return of 189.45%. However, the 5-year total shareholder return remains down 43.71% from earlier peaks.
Scan beyond FIGS and see which other healthcare and consumer companies are showing similar breakout behaviour in our curated list of 19 high quality undiscovered gems
FIGS now trades near levels that imply a very different story from the one investors told a year ago. Is this surge mainly a catch up to the underlying business, or a sentiment swing that the valuation section needs to unpack?
Most Popular Narrative: 52% Overvalued
The most followed FIGS narrative pegs fair value at $14.39 per share, well below the recent $21.94 close. This frames the latest surge as rich versus that anchor.
The company, on an absolute basis, is still growing well. Further, it has several growth levers, such as expanding its product range, entering new markets, and leaning into its “TEAMS” offering.
See why 24 investors see FIGS as 52% overvalued.
Using a 9% discount rate, the narrative suggests the current price embeds far more optimism than the fair value of $14.39 implies, despite FIGS generating $710.08m in revenue and $61.92m in net income with high quality earnings and improved profit margins of 8.7% compared with 1.3% a year earlier.
According to julio, this story leans heavily on brand strength with a direct to consumer model, a focused niche in healthcare professionals, and expansion vectors such as TEAMS orders, physical retail, and new product categories. It also flags execution risk, FX exposure, and sensitivity to economic cycles as constraints on what investors might reasonably pay.
Result: Fair Value of $14.39 (OVERVALUED)
Still, two pressure points could quickly change this FIGS story: a stumble on margin targets or a sharper hit from economic or FX headwinds.
Find out about the key risks to this FIGS narrative.
Next Steps
Mixed feelings about FIGS so far? Act on that, not someone else’s narrative, by weighing both the upside and the caution signs in the 2 key rewards and 1 important warning sign.
Looking for more FIGS-like investment ideas?
Do not stop with FIGS. Give yourself options by lining up a few fresh watchlist candidates that match your risk, income, and quality preferences.
- Stack the odds toward quality by filtering for resilient businesses with lower measured risk using the 31 resilient stocks with low risk scores.
- Hunt for potential value opportunities by screening for companies that pair solid fundamentals with prices that look appealing through the 35 high quality undervalued stocks.
- Build a watchlist of future watchlist candidates by surfacing financially robust businesses that are not yet widely followed via the 19 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com